Joelle Hallak - Associate Director, HEOR Real World Evidence (RWE) Analytics - AbbVie | LinkedIn
Transnational cancer research lab | Felsenstein Medical Research Center
Prof. Ruth Shalgi-Harsina | Sackler Faculty of Medicine
Posttraumatic Growth in Breast Cancer Survivors: Constructive and Illusory Aspects - Pat‐Horenczyk - 2015 - Journal of Traumatic Stress - Wiley Online Library
EX-99.1 2 f6k060319ex99-1_canfitebio.htm PRESS RELEASE DATED JUNE 3, 2019 Exhibit
Transnational cancer research lab | Felsenstein Medical Research Center
References in First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised ...
Matthew L. Meyerson, MD, PhD - DF/HCC
Findings from Can-Fite's Phase II Liver Cancer Study were Presented at ASCO Annual Meeting Late-Breaking Session | Business Wire
Prof. Naphtali Savion | Sackler Faculty of Medicine
UT Southwestern Radiation Oncology - Congratulations to Dr. Prasanna Alluri, Assistant Professor of Radiation Oncology at UT Southwestern, and Dr. Salomon Stemmer, Professor in Oncology at Rabin Medical Center, for being awarded
COVID Booster May Benefit Active-Treatment Cancer Patients
Pharma - Mor Research Applications
Kimberly Lynn Blackwell, MD | medicine.duke.edu
Past Seminars - Health Care Management
More Data on COVID-19 Vaccination and Cancer | Cancer Today
Supplemental Materials for First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre ...
Study: COVID-19 shots shown effective in cancer patients up to 4 months later - UPI.com
COVID-fighting antibodies last 4+ months in 87% of cancer patients: Israeli MDs | The Times of Israel
Posttraumatic Growth in Breast Cancer Survivors: Constructive and Illusory Aspects - Pat‐Horenczyk - 2015 - Journal of Traumatic Stress - Wiley Online Library
Joelle Hallak - Associate Director, HEOR Real World Evidence (RWE) Analytics - AbbVie | LinkedIn
Study: COVID-19 shots shown effective in cancer patients up to 4 months later - UPI.com
Leadership – CTG-Pharma
First-of-its-kind study in Israel finds that cancer patients are safe for COVID-19 vaccines - EJP
References in Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial - The Lancet
